174 related articles for article (PubMed ID: 29304437)
1. Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors.
Karandish F; Froberg J; Borowicz P; Wilkinson JC; Choi Y; Mallik S
Colloids Surf B Biointerfaces; 2018 Mar; 163():225-235. PubMed ID: 29304437
[TBL] [Abstract][Full Text] [Related]
2. Nucleus-Targeted, Echogenic Polymersomes for Delivering a Cancer Stemness Inhibitor to Pancreatic Cancer Cells.
Karandish F; Mamnoon B; Feng L; Haldar MK; Xia L; Gange KN; You S; Choi Y; Sarkar K; Mallik S
Biomacromolecules; 2018 Oct; 19(10):4122-4132. PubMed ID: 30169024
[TBL] [Abstract][Full Text] [Related]
3. Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors.
Mamnoon B; Loganathan J; Confeld MI; De Fonseka N; Feng L; Froberg J; Choi Y; Tuvin DM; Sathish V; Mallik S
ACS Appl Bio Mater; 2021 Feb; 4(2):1450-1460. PubMed ID: 33954285
[TBL] [Abstract][Full Text] [Related]
4. Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties.
Liu X; Huang J; Xie Y; Zhou Y; Wang R; Lou J
Med Sci Monit; 2019 Nov; 25():8905-8912. PubMed ID: 31760402
[TBL] [Abstract][Full Text] [Related]
5. Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin.
Zhang Y; Jin Z; Zhou H; Ou X; Xu Y; Li H; Liu C; Li B
Cancer Med; 2016 Jun; 5(6):1251-8. PubMed ID: 26899963
[TBL] [Abstract][Full Text] [Related]
6. iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.
Simón-Gracia L; Hunt H; Scodeller P; Gaitzsch J; Kotamraju VR; Sugahara KN; Tammik O; Ruoslahti E; Battaglia G; Teesalu T
Biomaterials; 2016 Oct; 104():247-57. PubMed ID: 27472162
[TBL] [Abstract][Full Text] [Related]
7. Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor.
Hubbard JM; Grothey A
Drugs; 2017 Jul; 77(10):1091-1103. PubMed ID: 28573435
[TBL] [Abstract][Full Text] [Related]
8. Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells.
Han D; Yu T; Dong N; Wang B; Sun F; Jiang D
J Exp Clin Cancer Res; 2019 Jul; 38(1):289. PubMed ID: 31277685
[TBL] [Abstract][Full Text] [Related]
9. Suppression of cancer relapse and metastasis by inhibiting cancer stemness.
Li Y; Rogoff HA; Keates S; Gao Y; Murikipudi S; Mikule K; Leggett D; Li W; Pardee AB; Li CJ
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1839-44. PubMed ID: 25605917
[TBL] [Abstract][Full Text] [Related]
10. The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone.
Shao Z; Wang H; Ren H; Sun Y; Chen X
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570646
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo.
Thulin MH; Määttä J; Linder A; Sterbova S; Ohlsson C; Damber JE; Widmark A; Persson E
Prostate; 2021 Jun; 81(8):452-462. PubMed ID: 33822400
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Localizing Peptide-Conjugated, Redox-Sensitive Polymersomes for Delivering Curcumin and Doxorubicin to Pancreatic Cancer Microtumors.
Anajafi T; Yu J; Sedigh A; Haldar MK; Muhonen WW; Oberlander S; Wasness H; Froberg J; Molla MS; Katti KS; Choi Y; Shabb JB; Srivastava DK; Mallik S
Mol Pharm; 2017 Jun; 14(6):1916-1928. PubMed ID: 28493710
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.
Zhang J; Wang L; Fai Chan H; Xie W; Chen S; He C; Wang Y; Chen M
Sci Rep; 2017 May; 7():46057. PubMed ID: 28470171
[TBL] [Abstract][Full Text] [Related]
14. Tissue-Penetrating, Hypoxia-Responsive Echogenic Polymersomes For Drug Delivery To Solid Tumors.
Kulkarni P; Haldar MK; Karandish F; Confeld M; Hossain R; Borowicz P; Gange K; Xia L; Sarkar K; Mallik S
Chemistry; 2018 Aug; 24(48):12490-12494. PubMed ID: 29968262
[TBL] [Abstract][Full Text] [Related]
15. iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells.
Mao X; Liu J; Gong Z; Zhang H; Lu Y; Zou H; Yu Y; Chen Y; Sun Z; Li W; Li B; Gao J; Zhong Y
Nanomedicine (Lond); 2015; 10(17):2677-95. PubMed ID: 26355733
[TBL] [Abstract][Full Text] [Related]
16. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
Hu C; Huang Y; Chen Y
Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
[TBL] [Abstract][Full Text] [Related]
17. Cellular Uptake and Cytotoxic Effect of Epidermal Growth Factor Receptor Targeted and Plitidepsin Loaded Co-Polymeric Polymersomes on Colorectal Cancer Cell Lines.
Goñi-de-Cerio F; Thevenot J; Oliveira H; Pérez-Andrés E; Berra E; Masa M; Suárez-Merino B; Lecommandoux S; Heredia P
J Biomed Nanotechnol; 2015 Nov; 11(11):2034-49. PubMed ID: 26554161
[TBL] [Abstract][Full Text] [Related]
18. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
Wang K; Zhang X; Liu Y; Liu C; Jiang B; Jiang Y
Biomaterials; 2014 Oct; 35(30):8735-47. PubMed ID: 25023394
[TBL] [Abstract][Full Text] [Related]
19. Prostate-Specific Membrane Antigen Targeted Polymersomes for Delivering Mocetinostat and Docetaxel to Prostate Cancer Cell Spheroids.
Karandish F; Haldar MK; You S; Brooks AE; Brooks BD; Guo B; Choi Y; Mallik S
ACS Omega; 2016 Nov; 1(5):952-962. PubMed ID: 27917408
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors.
Confeld MI; Mamnoon B; Feng L; Jensen-Smith H; Ray P; Froberg J; Kim J; Hollingsworth MA; Quadir M; Choi Y; Mallik S
Mol Pharm; 2020 Aug; 17(8):2849-2863. PubMed ID: 32521162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
